{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:12:20Z","timestamp":1790543540298,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Non-invasive phenotyping of chronic respiratory diseases would be highly beneficial in the personalised medicine of the future. Volatile organic compounds can be measured in the exhaled breath and may be produced or altered by disease processes. We investigated whether distinct patterns of these compounds were present in chronic obstructive pulmonary disease (COPD) and clinically relevant disease phenotypes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Breath samples from 39 COPD subjects and 32 healthy controls were collected and analysed using gas chromatography time-of-flight mass spectrometry. Subjects with COPD also underwent sputum induction. Discriminatory compounds were identified by univariate logistic regression followed by multivariate analysis: 1. principal component analysis; 2. multivariate logistic regression; 3. receiver operating characteristic (ROC) analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Comparing COPD <jats:italic>versus<\/jats:italic> healthy controls, principal component analysis clustered the 20 best-discriminating compounds into four components explaining 71% of the variance. Multivariate logistic regression constructed an optimised model using two components with an accuracy of 69%. The model had 85% sensitivity, 50% specificity and ROC area under the curve of 0.74. Analysis of COPD subgroups showed the method could classify COPD subjects with far greater accuracy. Models were constructed which classified subjects with \u22652% sputum eosinophilia with ROC area under the curve of 0.94 and those having frequent exacerbations 0.95. Potential biomarkers correlated to clinical variables were identified in each subgroup.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The exhaled breath volatile organic compound profile discriminated between COPD and healthy controls and identified clinically relevant COPD subgroups. If these findings are validated in prospective cohorts, they may have diagnostic and management value in this disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1465-9921-13-72","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T12:13:53Z","timestamp":1345724033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study"],"prefix":"10.1186","volume":"13","author":[{"given":"Maria","family":"Basanta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baharudin","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Dockry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Douce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Woodcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,23]]},"reference":[{"issue":"6","key":"1275_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","volume":"176","author":"KF Rabe","year":"2007","unstructured":"Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007, 176 (6): 532-555. 10.1164\/rccm.200703-456SO.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"1275_CR2","first-page":"1","volume":"59","author":"Chronic obstructive pulmonary disease","year":"2004","unstructured":"Chronic obstructive pulmonary disease: National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004, 59 (Suppl 1): 1-232.","journal-title":"Thorax"},{"issue":"5","key":"1275_CR3","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1164\/ajrccm.153.5.8630597","volume":"153","author":"J Vestbo","year":"1996","unstructured":"Vestbo J, Prescott E, Lange P: Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity, Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996, 153 (5): 1530-1535.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"1275_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/thorax.57.10.847","volume":"57","author":"GC Donaldson","year":"2002","unstructured":"Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002, 57 (10): 847-852. 10.1136\/thorax.57.10.847.","journal-title":"Thorax"},{"issue":"3","key":"1275_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/thx.2004.032516","volume":"60","author":"CE Brightling","year":"2005","unstructured":"Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, et al: Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax. 2005, 60 (3): 193-198. 10.1136\/thx.2004.032516.","journal-title":"Thorax"},{"issue":"7","key":"1275_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1164\/rccm.201004-0602ED","volume":"182","author":"J Vestbo","year":"2010","unstructured":"Vestbo J, Rennard S: Chronic Obstructive Pulmonary Disease Biomarker(s) for Disease Activity Needed\u2013Urgently. Am J Respir Crit Care Med. 2010, 182 (7): 863-864. 10.1164\/rccm.201004-0602ED.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1275_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.rmed.2009.10.018","volume":"104","author":"JJ Van Berkel","year":"2010","unstructured":"Van Berkel JJ, Dallinga JW, Moller GM, Godschalk RW, Moonen EJ, Wouters EF, Van Schooten FJ: A profile of volatile organic compounds in breath discriminates COPD patients from controls. Respir Med. 2010, 104 (4): 557-563. 10.1016\/j.rmed.2009.10.018.","journal-title":"Respir Med"},{"issue":"2","key":"1275_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1039\/b916374c","volume":"135","author":"M Basanta","year":"2010","unstructured":"Basanta M, Jarvis RM, Xu Y, Blackburn G, Tal-Singer R, Woodcock A, Singh D, Goodacre R, Thomas CL, Fowler SJ: Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst. 2010, 135 (2): 315-320. 10.1039\/b916374c.","journal-title":"Analyst"},{"key":"1275_CR9","unstructured":"Fens N, de Nijs SB, Peters S, Dekker T, Knobel HH, Vink TJ, Willard NP, Zwinderman AH, Krouwels FH, Janssen HG, et al: Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Eur Respir J."},{"issue":"2","key":"1275_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1183\/09031936.00036411","volume":"39","author":"A Motta","year":"2012","unstructured":"Motta A, Paris D, Melck D, de Laurentiis G, Maniscalco M, Sofia M, Montuschi P: Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects. Eur Respir J. 2012, 39 (2): 498-500. 10.1183\/09031936.00036411.","journal-title":"Eur Respir J"},{"key":"1275_CR11","doi-asserted-by":"crossref","unstructured":"Ibrahim B, Basanta M, Cadden P, Singh D, Douce D, Woodcock A, Fowler SJ: Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax. 66 (9): 804-809.","DOI":"10.1136\/thx.2010.156695"},{"issue":"4","key":"1275_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1183\/09031936.00111707","volume":"31","author":"J Vestbo","year":"2008","unstructured":"Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, et al: Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J. 2008, 31 (4): 869-873. 10.1183\/09031936.00111707.","journal-title":"Eur Respir J"},{"issue":"2","key":"1275_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al: Standardisation of spirometry. Eur Respir J. 2005, 26 (2): 319-338. 10.1183\/09031936.05.00034805.","journal-title":"Eur Respir J"},{"issue":"6","key":"1275_CR14","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1183\/09031936.96.09061174","volume":"9","author":"E Pizzichini","year":"1996","unstructured":"Pizzichini E, Pizzichini MM, Efthimiadis A, Hargreave FE, Dolovich J: Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J. 1996, 9 (6): 1174-1180. 10.1183\/09031936.96.09061174.","journal-title":"Eur Respir J"},{"key":"1275_CR15","doi-asserted-by":"crossref","unstructured":"Basanta M, Ibrahim B, Douce D, Morris M, Woodcock A, Fowler SJ: Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds. J Breath Res. 6 (2): 026002-","DOI":"10.1088\/1752-7155\/6\/2\/026002"},{"issue":"1","key":"1275_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jchromb.2007.11.008","volume":"861","author":"JJ Van Berkel","year":"2008","unstructured":"Van Berkel JJ, Dallinga JW, Moller GM, Godschalk RW, Moonen E, Wouters EF, Van Schooten FJ: Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air. J Chromatogr B Analyt Technol Biomed Life Sci. 2008, 861 (1): 101-107. 10.1016\/j.jchromb.2007.11.008.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"5","key":"1275_CR17","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jaci.2010.02.008","volume":"125","author":"AT Hastie","year":"2010","unstructured":"Hastie AT, Moore WC, Meyers DA, Vestal PL, Li H, Peters SP, Bleecker ER: Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol. 2010, 125 (5): 1028-1036. 10.1016\/j.jaci.2010.02.008. e1013","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1275_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11306-010-0228-5","volume":"6","author":"JL Izquierdo-Garc\u00eda","year":"2010","unstructured":"Izquierdo-Garc\u00eda JL, Puerto-Nevado L, Peces-Barba G, P\u00e9rez-Rial S, Heili S, Villa P, Castej\u00f3n D, Gonz\u00e1lez-Mangado N, Ruiz-Cabello N: A metabonomic approach to evaluate COPD in a model of cigarette smoke exposure in mice. Metabolomics. 2010, 6 (4): 564-573. 10.1007\/s11306-010-0228-5.","journal-title":"Metabolomics"},{"issue":"2","key":"1275_CR19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/CBM-2007-3204","volume":"3","author":"M Phillips","year":"2007","unstructured":"Phillips M, Altorki N, Austin JH, Cameron RB, Cataneo RN, Greenberg J, Kloss R, Maxfield RA, Munawar MI, Pass HI, et al: Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark. 2007, 3 (2): 95-109.","journal-title":"Cancer Biomark"},{"issue":"4","key":"1275_CR20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","volume":"39","author":"MH Zweig","year":"1993","unstructured":"Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993, 39 (4): 561-577.","journal-title":"Clin Chem"},{"issue":"4","key":"1275_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1042\/BST0370819","volume":"037","author":"W MacNee","year":"2009","unstructured":"MacNee W: Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). Biochem Soc Trans. 2009, 037 (4): 819-823. 10.1042\/BST0370819.","journal-title":"Biochem Soc Trans"},{"key":"1275_CR22","doi-asserted-by":"crossref","unstructured":"Singh D, Edwards L, Tal-Singer R, Rennard S: Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respir Res. 11: 77-","DOI":"10.1186\/1465-9921-11-77"},{"issue":"7 Pt 2","key":"1275_CR23","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/clinchem\/40.7.1401","volume":"40","author":"DL Ashley","year":"1994","unstructured":"Ashley DL, Bonin MA, Cardinali FL, McCraw JM, Wooten JV: Blood concentrations of volatile organic compounds in a nonoccupationally exposed US population and in groups with suspected exposure. Clin Chem. 1994, 40 (7 Pt 2): 1401-1404.","journal-title":"Clin Chem"},{"issue":"1\u20132","key":"1275_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0378-4347(99)00127-9","volume":"729","author":"M Phillips","year":"1999","unstructured":"Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo RN: Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl. 1999, 729 (1\u20132): 75-88.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"5","key":"1275_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1165\/rcmb.2007-0130OC","volume":"37","author":"F Facchinetti","year":"2007","unstructured":"Facchinetti F, Amadei F, Geppetti P, Tarantini F, Di Serio C, Dragotto A, Gigli PM, Catinella S, Civelli M, Patacchini R: Alpha, beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am J Respir Cell Mol Biol. 2007, 37 (5): 617-623. 10.1165\/rcmb.2007-0130OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"13","key":"1275_CR26","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jchromb.2009.01.036","volume":"877","author":"P Montuschi","year":"2009","unstructured":"Montuschi P: LC\/MS\/MS analysis of leukotriene B4 and other eicosanoids in exhaled breath condensate for assessing lung inflammation. J Chromatogr B Analyt Technol Biomed Life Sci. 2009, 877 (13): 1272-80. 10.1016\/j.jchromb.2009.01.036.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-13-72.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:30:06Z","timestamp":1630528206000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-13-72"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,23]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1275"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-13-72","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,23]]},"assertion":[{"value":"12 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"72"}}